• PDF: Delivered by email usually within 4 to 8 UK business hours.

Cambodia and Laos Telecommunications Report Q1 2013

  • Publication Date:February 2013
  • Publisher:Business Monitor
  • Product Type: Report
  • Pages:60
  • ISBN:177154

Cambodia and Laos Telecommunications Report Q1 2013



Includes 3 FREE quarterly updates
BMI View: Rampant corruption will continue to be one of the key factors hindering the development of the
pharmaceutical and healthcare sectors in Cambodia. In addition, improving conditions in neighbouring
countries such as Vietnam and Thailand mean Cambodia will be seen as relatively unattractive to investors,
which does not help in the advancement of these sectors.


Headline Expenditure Projections

- Pharmaceuticals: KHR651.8bn (US$161mn) in 2011 to KHR723.3bn (US$173mn) in 2012; +11% in
local currency terms and +7.7% in US dollar terms. Growth forecast downgraded due to lower than
expected pharmaceutical trade imports.
- Healthcare: KHR2,982bn (US$737mn) in 2011 to KHR3,312bn (US$794mn) in 2012; +11.1% in local
currency terms and +7.8% in US dollar terms. Forecast unchanged from Q412.
- Medical Devices: KHR107.5bn (US$27mn) in 2011 to KHR118.1bn (US$28mn) in 2011; +9.8% in local
currency terms and +6.6% in US dollar terms. Forecast unchanged from Q412.
BMI Industry View 7
SWOT 9
Industry Forecast .. 11
Pharmaceutical Market Forecast . 11
Table: Pharmaceutical Sales Indicators, 2008-2016 . . 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Indicators, 2008-2016 14
Table: Healthcare Governmental Indicators, 2008-2016 . . 15
Table: Healthcare Private Indicators 2008-2016 . . 15
Pharmaceutical Trade Forecast .. 15
Table: Pharmaceutical Trade Indicators, 2008-2016 . 17
Medical Devices Market Forecast 18
Table: Table: Medical Devices Sales Indicators 2008-2016 . . 19
Other Healthcare Data .. 19
Economic Analysis .. 20
Industry Risk Reward Ratings 23
Table: Table: Asia Pacific Pharmaceutical Risk/Reward Ratings, Q113 . . 23
Rewards .. 24
Risks . 25
Market Overview 26
Industry Trends And Developments .. 27
Epidemiology . 27
Healthcare Sector . 29
Health Insurance .. 30
Research & Development 31
Clinical Trials 31
Medical Devices 32
Regulatory Development .. 33
Regulatory Regime 33
Intellectual Property Issues . 33
Counterfeit Medicines .. 34
Pricing And Reimbursement 36
Competitive Landscape . 38
Pharmaceutical Industry . 38
Company Developments .. 40
Pharmaceutical Wholesale .. 40
Pharmaceutical Retail .. 41
Company Profile . 43
PharmaProduct Manufacturing (PPM) .. 43
Cambodia Pharmaceutical Enterprise - Q1 2013 . 46
Sanofi . 48
Pfizer . 50
Demographic Forecast .. 52
Demographic Forecast - Cambodia 52
Table: Cambodia's Population By Age Group, 1990-2020 ('000) . . 53
Table: Cambodia's Population By Age Group, 1990-2020 (% of total) 54
Table: Cambodia's Key Population Ratios, 1990-2020 55
Table: Cambodia's Rural And Urban Population, 1990-2020 . 55
Glossary .. 56
Methodology . 58
Methodology . 58
Risk/Reward Ratings Methodology 58
Ratings Overview .. 59
Table: Pharmaceutical Business Environment Indicators . . 59
Weighting 60
Table: Weighting Of Components . . 60
Sources 60
+44 20 8816 8548

Ask a question about Cambodia and Laos Telecommunications Report Q1 2013

Enter the characters you see in the picture below
Captcha